Answers are grounded in this paper and cite their sources.
Review reveals farnesol acts as a multifunctional regulator linking signaling to metabolism across fungi, suggesting novel strategies to combat antifungal tolerance.
Farnesol is a small isoprenoid metabolite that has emerged as a key regulator of fungal biology beyond its original identification as a quorum-sensing molecule in Candida albicans. This review examines farnesol across pathogenic and non-pathogenic fungi, emphasizing its roles in morphogenesis, biofilm development, stress adaptation, membrane-associated physiology, and ecological interaction. In pathogenic fungi, farnesol modulates virulence-related traits, antifungal susceptibility, and host interaction, while in non-pathogenic systems, it influences growth, differentiation, and metabolic balance. Evidence from Saccharomyces cerevisiae, Trichoderma, Candidozyma auris (formerly known as Candida auris), and other fungi highlights the context-dependent nature of its effects. We also discuss farnesol biosynthesis, secretion, and the apparent absence of canonical salvage pathways in fungi. Together, these findings support a broader view of farnesol as a multifunctional fungal metabolite that links signaling with metabolism. Understanding its diverse biological roles may clarify fungal evolution and inform future strategies targeting fungal persistence, adaptation, and antifungal tolerance.
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: